Kite Pharma Competitors and Similar CompaniesClear all
Kite Pharma's competitors and similar companies include G1 Therapeutics, Achilles Therapeutics and Amgen.
 G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. |  Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ||
Founding Date | Founding Date 2009 | Founding Date 2008 | Founding Date 2016 | Founding Date 1980 |
Type | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Durham, US HQ | Locations London, GB HQ Stevenage, GB | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more |
Employees | Employees 3,9671% decrease | Employees 17015% increase | Employees 695% decrease | Employees 25,200 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 377.2 m | Valuation ($) N/A | Valuation ($) 170.4 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $36.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $7.2m (FY, 2023) | Cost of goods N/A | Cost of goods $12b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $75.3m (FY, 2023) | Gross profit N/A | Gross profit $24.7b (FY, 2025) |
Net income | Net income N/A | Net income ($48m) (FY, 2023) | Net income ($69.7m) (FY, 2023) | Net income $7.7b (FY, 2025) |
Operating ⚠ | ||||
Patents (US) | Patents (US) N/A | Patents (US) 40 (FY, 2020) | Patents (US) N/A | Patents (US) 31 (FY, 2020) |
Trademarks (US) | Trademarks (US) 19 (Jan, 2024) | Trademarks (US) N/A | Trademarks (US) 3 (May, 2021) | Trademarks (US) N/A |
Funding | ||||
Total funding raised | Total funding raised $ 85.3m | Total funding raised $ 289.6m | Total funding raised $ 138.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
G1 Therapeutics
HQ
Durham, US
Employees
170↑ 15% increase
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View companyAchilles Therapeutics
HQ
London, GB
Employees
69↓ 5% decrease
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
View companyAmgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company